The growing number of biological drugs such as monoclonal antibodies (mAbs), as well as the wealth of heterogeneity between mAb variants requires a thorough development process to maximize mAbs compliance with regulation. Therefore, biophysical analytical methods are required already at early stages of the development process to guide and streamline further antibody processing and to predict antibody developability. In this case study, we demonstrate how the Prometheus NT.48 can be used to predict long-term mAb stability in a formulation screen by simultaneous quantification of both, conformational and colloidal stability of biologicals in thermal gradients.
Home
»
Application Notes
»
Analysis of formulation-dependent colloidal and conformational stability of monoclonal antibodies
×
Share
Have a question about Prometheus?
Contact SpecialistMost recent content
Use of self-interaction parameters derived from light scattering experiments for better developability assessment of biologic therapeutics
Quantifying oligonucleotides binding to human serum albumin with MST: A faster and precise approach for drug candidates ADME profiling
Fast molecular interaction screening of epigenetic gene regulator G9a with fragments from a large chemical space
Rapid Quantification of Unfolded Proteins for Quality Control and Optimization of Storage Conditions
Protein labeling – improved quantitation of biomolecular interactions by MST using the RED-NHS 2nd generation labeling kit
One-step, purification-free and site-specific labeling of polyhistidine-tagged proteins for MST
Anaerobic MicroScale Thermophoresis reveals the redox dependency of ferredoxin in mitochondrial Fe/S biogenesis
The decondensation factor 31 specifically interacts with histones H3 and H4 but not H2A and H2B